Amgen Inc. buy BMO Capital Markets
Start price
03.05.24
/
50%
€292.50
Target price
03.05.25
€329.44
Performance (%)
2.76%
Price
28.08.24
€296.45
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 2.76%. Dividends of €4.11 are taken into consideration when calculating the performance. This prediction currently runs until 03.05.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 0.406% | 0.406% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at BMO Capital Markets from $336.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat